(Q44658883)

5 December 2017

title

New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains (English)

1 reference

5 December 2017

New classes of antibacterial oxazolidinones with C-5, methylene O-Linked heterocyclic side chains (English)

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

3 April 2024

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

3 April 2024

author name string

Michael Dennis

4

1 reference

5 December 2017

Glenn Hatter

5

1 reference

5 December 2017

Alexandra McGregor

6

1 reference

5 December 2017

Lisa Woods

9

1 reference

5 December 2017

Alan Wookey

10

1 reference

5 December 2017

Michael B. Gravestock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622997

3 April 2024

David G. Acton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622997

3 April 2024

Michael J. Betts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622997

3 April 2024

Michael L. Swain

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622997

3 April 2024

R. Geoffrey Wilson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622997

3 April 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0960894X03008771?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

https://api.elsevier.com/content/article/PII:S0960894X03008771?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Bioorganic & Medicinal Chemistry Letters

3 April 2024

published in

1 reference

5 December 2017

volume

13

1 reference

5 December 2017

issue

23

1 reference

5 December 2017

page(s)

4179-4186

1 reference

Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop

5 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Linezolid resistance in a clinical isolate of Staphylococcus aureus

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" group

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

Antibacterials. synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.033

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference